How to Apply
We will start reviewing applications via ERAS for July 2025 when the next season of the match opens in September 2024.
No applications or documents will be received outside of the ERAS system.
Please check our website in the upcoming weeks for more information. If you have any questions, please email prmc.gme@lifepointhealth.net
We invite you to apply to our program via the Electronic Residency Application Service (ERAS). Our program participates in the National Resident Matching Program (NRMP) and adheres to its policies and guidelines. Our ERAS and NRMP numbers will be posted soon. Our programs do not accept applications sent outside of these systems.
Application timeline:
- Programs begin application review: September
- Interviews: October to January
- Ranking of candidates: January to March
- Match Week: Mid-March
All applicants will be reviewed by the program director and the review committee.
Eligibility Requirements for IM Residency Program
If you would like to be considered for application review and interview for the next Match season, please apply via ERAS when the season starts in September 2024. The program will not review nor consider any candidates that send out their applications outside of the system.
An applicant must meet the following qualifications to be eligible for an appointment to the Program:
- Graduation from a medical school in the United States or Canada, accredited by the Liaison Committee on Medical Education (LCME) or by the Commission on Osteopathic College Accreditation (COCA) or,
- Graduation from a medical school outside the Unites States or Canada:
- A valid ECFMG certificate must be obtained before submitting application with passing step 1 and step 2 scores.
- Graduation from medical school within the last 5 years WITH some kind of practice in the field of medicine
- Fluency in spoken and written English
- We will consider permanent resident status or J-1Visa who have exposure of clinical experience practicing direct patient care in the Unites States
- We do not sponsor H-1Visa